1 / 31

Contraception

Contraception. Alison Edelman, MD, MPH Associate Professor Co- Director, Family Planning Fellowship Obstetrics & Gynecology Oregon Health & Science University. Why do we care?. 29 % Unintended Despite method use. 51 % Intended. 20 % Unintended No method used.

lloyd
Télécharger la présentation

Contraception

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Contraception Alison Edelman, MD, MPH Associate Professor Co-Director, Family Planning Fellowship Obstetrics & Gynecology Oregon Health & Science University

  2. Why do we care? 29 % Unintended Despite method use 51 % Intended 20 % Unintended No method used Frost JJ, Guttmacher Institute, 2008

  3. Typical effectiveness of contraceptive methods Vasectomy More effective Less than 1 pregnancy per 100 women in one year Female Sterilization Implant IUD About 3-8 pregnancies per 100 women in one year Injectables Pills Patch Ring Lactation Amenorrhea About 30 pregnancies per 100 women in one year Female Condoms Male Condoms Fertility-Awareness Based Methods Diaphragm Sponge Spermicide Withdrawal Less effective Emergency Contraception adapted with permission from the WHO 2006

  4. Method Choice in the U.S. (2002) *Other includes diaphragm, ring, gel/foam, rods, and EC Alan Guttmacher Institute, Facts In Brief, 2005.

  5. IUD use Worldwide Estimated Use Among Married Women of Reproductive Age %UsingIUD NorthAmerica Asia Europe Latin America & Caribbean Oceania Africa Population Reference Bureau, 2002.

  6. Hormonal birth control

  7. What are the hormones? • Progestin component • 1st norethindrone • 2nd levonorgestrel • 3rd desogestrel • 4thantimineralocorticoid activity (drospirenone) • Estrogen component • EthinylEstradiol • High (50 mcg) • Low (<30-35 mcg) • Very low (< 20 mcg)

  8. How do they work? • Progestin • Prevents ovulation by suppressing LH secretion • Thins (decidualizes) endometrial lining • Thickens cervical mucus • Estrogen • Prevents emergence of a dominant follicle by suppressing FSH secretion • Stabilizes the endometrium • Potentiates the action of the progestational agent

  9. Combined Oral Contraceptives

  10. Prescribing Precautions(Estrogen-related) • Smoking ≥ 35 year old • H/O thrombotic disease in self • CVD (with/without diabetes, SLE) • Uncontrolled hypertension • Migraine • With Aura or focal neuro symptoms at any age • With or with out ≥ 35yo • Breast cancer- current or recent (w/in 5 yrs) • Endometrial cancer • Unexplained vaginal bleeding • Hepatic dysfunction, carcinoma, adenoma www.who.int – medical eligibility criteria

  11. Combined TransdermalPatchOrtho evra Ortho-McNeil

  12. Contraceptive vaginal ringNuvaring

  13. Progestin-only Pills

  14. InjectablesDepoProvera IM OR SQ • Progestin-only • Two formulations • IM q 12 weeks • SQ q 12 weeks • Typical use Failure 3% • Pros • 50% amenorrhea at 1 year • Confidential • Highly effective • Cons • Irregular bleeding • Delayed return to fertility • Possible weight gain – especially in already obese teens

  15. Transdermal Implant Implanon (1 rod) 68 mg etonogestrel AKA keto-desogestrel

  16. Implanon: insertion

  17. LNG IUD

  18. Levonorgestrel Serum Concentrations of Oral, Subdermal and Intrauterine Delivery Data on file. Berlex Laboratories, Inc. 1999

  19. “Don’t get me wrong. I think the morning after pill is great. It’s just that right now my problem is lining up something for the night before.” The New Yorker, July 23, 1999

  20. Non-hormonal birth control

  21. Non- hormonal Intrauterine DeviceParagard/copper T

  22. Female-Controlled Barrier Methods • Diaphragm • Requires fitting by a clinician • Use with spermicide • Typical use failure rate16% • Sponge • OTC, non-latex • Typical use failure rate13-16% • Female condom • OTC • Typical use failure rate 21% • Cervical caps • Lea’s Shield, FemCap- non-latex • Use with spermicide • Typical use failure rate 16-32%

  23. Barrier Methods • Male condoms • Typical use failure rate 15% • Latex, polyurethane, natural membrane • Water-based lubricants only • Prevent HIV transmission, reduce the risk of other STI’s (ie. gonorrhea, chlamydia, trichomonas) • Spermicides • Nonoxynol-9 available OTC in U.S. • Typical use failure rate 29% • May increase risk of HIV • Spermicidal condoms are no longer recommended

  24. Fertility Awareness methods or periodic abstinence

  25. Lactional amenorrhea

  26. Abstinence • Typical use “efficacy” unknown • Requires negotiation skills • Provide condoms and EC as back-up • Correct use provides STI/HIV protection

  27. Sterilization

  28. Initiation Timing • Sunday start* • Anytime during menses* • Immediately (Quick start)* • Immediately after EC* • Immediately after abortion or miscarriage • 3-6 weeks postpartum *Backup method for 7-10 days is a good idea!

More Related